Medical devices, healthcare technology and the business of care
510(k) clearance · K254240

Echo-2

Neko Health AB · Decision date Sep 22, 2026

MEDTECHLEDGER EXPLANATIONK254240

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision for Echo-2, a 510(k) submitted by Neko Health AB of Danderyd, Sweden, under number K254240. The decision date is 22 September 2026; the application was received 29 December 2025. The device falls under regulation 870.2786, classification product code QOK, with subsequent product code DXR, and the regulation medical specialty and 510(k) review panel are both Cardiovascular. The public record lists the device classification name as hardware and software for optical camera-based measurement of heart rate and respiratory rate.

SESE means the submission was cleared to market as substantially equivalent; it is not a PMA approval. The record describes a traditional 510(k) that was not reviewed by a third party, is not a combination product, and has no authorized predetermined change control plan. The page does not state which components, software versions or changes were assessed, nor does it give indications for use, performance data or comparison devices. Those details would sit in the underlying 510(k) documents, which are not included here.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Cardiovascular
Decision date
Sep 22, 2026
FDA decision documents: 510(k) Premarket Notification - FDA

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K254240
Regulatory pathway
510(k) premarket notification
Product code
QOK
Decision code
SESE
Decision date
Sep 22, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Hardware And Software For Optical Camera-Based Measurement Of Heart Rate And Respiratory Rate.

Product code
QOK
FDA device class
2

FDA decision timeline

  1. K254240 received

    Application receipt date recorded by FDA.

  2. K254240 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Neko Health AB

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Danderyd

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records